Kirsi Talala

2.8k total citations
78 papers, 1.3k citations indexed

About

Kirsi Talala is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Kirsi Talala has authored 78 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Pulmonary and Respiratory Medicine, 21 papers in Oncology and 17 papers in Cancer Research. Recurrent topics in Kirsi Talala's work include Prostate Cancer Treatment and Research (42 papers), Prostate Cancer Diagnosis and Treatment (33 papers) and Cancer, Lipids, and Metabolism (16 papers). Kirsi Talala is often cited by papers focused on Prostate Cancer Treatment and Research (42 papers), Prostate Cancer Diagnosis and Treatment (33 papers) and Cancer, Lipids, and Metabolism (16 papers). Kirsi Talala collaborates with scholars based in Finland, United States and Sweden. Kirsi Talala's co-authors include Ritva Prättälä, Anssi Auvinen, Teuvo L.J. Tammela, Tuija Martelin, Kimmo Taari, Satu Helakorpi, Teemu J. Murtola, Hanna Tolonen, Tiina Laatikainen and Ossi Rahkonen and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer.

In The Last Decade

Kirsi Talala

73 papers receiving 1.3k citations

Peers

Kirsi Talala
K. Sundquist United States
Adana A. M. Llanos United States
Erica T. Warner United States
Diana R. Withrow United States
Brian M. Rivers United States
Sonja Lumme Finland
Alison Fraser United States
Edward J. Saunders United States
Bettina F. Drake United States
Constantine Daskalakis United States
K. Sundquist United States
Kirsi Talala
Citations per year, relative to Kirsi Talala Kirsi Talala (= 1×) peers K. Sundquist

Countries citing papers authored by Kirsi Talala

Since Specialization
Citations

This map shows the geographic impact of Kirsi Talala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirsi Talala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirsi Talala more than expected).

Fields of papers citing papers by Kirsi Talala

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kirsi Talala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirsi Talala. The network helps show where Kirsi Talala may publish in the future.

Co-authorship network of co-authors of Kirsi Talala

This figure shows the co-authorship network connecting the top 25 collaborators of Kirsi Talala. A scholar is included among the top collaborators of Kirsi Talala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kirsi Talala. Kirsi Talala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Talala, Kirsi, Teuvo L.J. Tammela, Kimmo Taari, et al.. (2024). Long-term Risk of Prostate Cancer Mortality Among Men with Baseline Prostate-specific Antigen Below 3 ng/ml: Evidence from the Finnish Randomized Study of Screening for Prostate Cancer. European Urology Oncology. 8(2). 452–459. 1 indexed citations
2.
Talala, Kirsi, Sebastiaan Remmers, Teuvo L.J. Tammela, et al.. (2024). Which men benefit from prostate cancer screening? Prostate cancer mortality by subgroup in the European Randomised Study of Screening for Prostate Cancer. British Journal of Urology. 134(2). 291–299. 2 indexed citations
3.
Walter, Stephen D., Jiarui Hu, Kirsi Talala, et al.. (2021). Estimating the rate of overdiagnosis with prostate cancer screening: evidence from the Finnish component of the European Randomized Study of Screening for Prostate Cancer. Cancer Causes & Control. 32(11). 1299–1313. 9 indexed citations
4.
Siltari, Aino, Teemu J. Murtola, Kirsi Talala, et al.. (2020). Antihypertensive drug use and prostate cancer-specific mortality in Finnish men. PLoS ONE. 15(6). e0234269–e0234269. 16 indexed citations
5.
Sipeky, Csilla, Kirsi Talala, Teuvo L.J. Tammela, et al.. (2020). Prostate cancer risk prediction using a polygenic risk score. Scientific Reports. 10(1). 17075–17075. 22 indexed citations
6.
Talala, Kirsi, et al.. (2019). Charlson Comorbidity Index Based On Hospital Episode Statistics Performs Adequately In Predicting Mortality, But Its Discriminative Ability Diminishes Over Time. SHILAP Revista de lepidopterología. 2 indexed citations
7.
Murtola, Teemu J., et al.. (2019). Anticoagulants and cancer mortality in the Finnish randomized study of screening for prostate cancer. Cancer Causes & Control. 30(8). 877–888. 7 indexed citations
8.
Sipeky, Csilla, Ping Gao, Qin Zhang, et al.. (2018). Synergistic Interaction of HOXB13 and CIP2A Predisposes to Aggressive Prostate Cancer. Clinical Cancer Research. 24(24). 6265–6276. 21 indexed citations
9.
Pakarainen, Tomi, Jaakko Nevalainen, Kirsi Talala, et al.. (2018). The Number of Screening Cycles Needed to Reduce Prostate Cancer Mortality in the Finnish Section of the European Randomized Study of Prostate Cancer (ERSPC). Clinical Cancer Research. 25(2). 839–843. 6 indexed citations
10.
Siltari, Aino, Teemu J. Murtola, Kirsi Talala, et al.. (2018). Antihypertensive drugs and prostate cancer risk in a Finnish population-based cohort. Scandinavian Journal of Urology. 52(5-6). 321–327. 10 indexed citations
11.
Murtola, Teemu J., et al.. (2018). Serum cholesterol and prostate cancer risk in the Finnish randomized study of screening for prostate cancer. Prostate Cancer and Prostatic Diseases. 22(1). 66–76. 28 indexed citations
12.
Kaipia, Antti, Kirsi Talala, Kimmo Taari, et al.. (2017). Allopurinol and risk of benign prostatic hyperplasia in a Finnish population-based cohort. Prostate Cancer and Prostatic Diseases. 21(3). 373–378. 8 indexed citations
13.
Murtola, Teemu J., et al.. (2017). Prostate cancer-specific survival among warfarin users in the Finnish Randomized Study of Screening for Prostate Cancer. BMC Cancer. 17(1). 585–585. 7 indexed citations
14.
15.
Murtola, Teemu J., Kirsi Talala, Liisa Määttänen, et al.. (2016). Statin Use and Prostate Cancer Survival in the Finnish Randomized Study of Screening for Prostate Cancer. European Urology Focus. 3(2-3). 212–220. 44 indexed citations
16.
Kilpeläinen, Tuomas P., Tuukka Mäkinen, Pekka J. Karhunen, et al.. (2016). Estimating bias in causes of death ascertainment in the Finnish Randomized Study of Screening for Prostate Cancer. Cancer Epidemiology. 45. 1–5. 17 indexed citations
17.
Murtola, Teemu J., et al.. (2016). Digoxin and prostate cancer survival in the Finnish Randomized Study of Screening for Prostate Cancer. British Journal of Cancer. 115(11). 1289–1295. 13 indexed citations
18.
Talala, Kirsi, Taina Huurre, Tiina Laatikainen, et al.. (2011). The contribution of psychological distress to socio-economic differences in cause-specific mortality: a population-based follow-up of 28 years. BMC Public Health. 11(1). 138–138. 8 indexed citations
19.
Roos, E, Kirsi Talala, Mikko Laaksonen, et al.. (2007). Trends of socioeconomic differences in daily vegetable consumption, 1979–2002. European Journal of Clinical Nutrition. 62(7). 823–833. 60 indexed citations
20.
Tolonen, Hanna, Satu Helakorpi, Kirsi Talala, et al.. (2006). 25-year Trends and Socio-demographic Differences in Response Rates: Finnish Adult Health Behaviour Survey. European Journal of Epidemiology. 21(6). 409–415. 226 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K. Sundquist Breakdown of academic impact, for papers by Adana A. M. Llanos Breakdown of academic impact, for papers by Erica T. Warner Breakdown of academic impact, for papers by Diana R. Withrow Breakdown of academic impact, for papers by Brian M. Rivers Breakdown of academic impact, for papers by Sonja Lumme Breakdown of academic impact, for papers by Alison Fraser Breakdown of academic impact, for papers by Edward J. Saunders Breakdown of academic impact, for papers by Bettina F. Drake Breakdown of academic impact, for papers by Constantine Daskalakis
Rankless by CCL
2026